Catching It Early: The Role of Screening in Dementia and Alzheimer’s Care
In this video, PA Klingler introduces the prevalence and burden of cognitive impairment, including mild cognitive impairment (MCI) and Alzheimer’s Disease, with an emphasis on early identification and screening in primary care. Drawing from recent research—including a 2024 analysis of Medicare data showing over 90% of MCI cases go undiagnosed—PA Klingler highlights the critical opportunity for PAs to intervene earlier in the disease process.
Key Takeaways:
- Mild cognitive impairment is vastly underdiagnosed.
- Medicare requires screening of anyone over age 65, but it is appropriate to screen younger patients with any cognition concerns.
- The AD8 and MiniCog are useful screening tools.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
Alzheimer’s Association. 2025 Alzheimer’s Disease Facts and Figures: American Perspectives on Early Detection of Alzheimer’s Disease in the Era of Treatment.; 2025. Accessed July 23, 2025. https://www.alz.org/getmedia/ef8f48f9-ad36-48ea-87f9-b74034635c1e/alzheimers-facts-and-figures.pdf
American Academy of Physician Associates. Cognitive Assessment Toolkit. Aapa.org. 2025. Accessed July 23, 2025. https://www.aapa.org/cme-central/cognitive-assessment-toolkit/
Detecting Alzheimer’s disease: Older adults’ experiences with cognitive screening & blood biomarker testing. National Poll on Healthy Aging. Accessed July 23, 2025. https://www.healthyagingpoll.org/reports-more/report/detecting-alzheimers-disease-older-adults-experiences-cognitive-screening-blood
KAER toolkit. Kaerbrain.org. Accessed July 23, 2025. https://www.kaerbrain.org/
Liu Y, Jun H, Becker A, Wallick C, Mattke S. Detection rates of mild cognitive impairment in primary care for the United States Medicare population. J Prev Alzheimers Dis. 2024;11(1):7-12. doi:10.14283/jpad.2023.131
Song WX, Wu WW, Zhao YY, et al. Evidence from a meta-analysis and systematic review reveals the global prevalence of mild cognitive impairment. Front Aging Neurosci. 2023;15:1227112. doi:10.3389/fnagi.2023.1227112
Supported by
